{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:10:19Z","timestamp":1790298619746,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00430-025-00827-1","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T15:03:06Z","timestamp":1743087786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CRISPR\/Cas9-mediated deletion of a kinetoplast-associated gene attenuates virulence in Leishmania major parasites"],"prefix":"10.1007","volume":"214","author":[{"given":"Fatemeh","family":"Darzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khamesipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoo","family":"Tasbihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Bahraminasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Nateghi-Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"827_CR1","doi-asserted-by":"crossref","unstructured":"Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R Leishmaniasis: a review. F1000Research 2017;6.","DOI":"10.12688\/f1000research.11120.1"},{"key":"827_CR2","first-page":"1","volume":"26","author":"L Abdellahi","year":"2022","unstructured":"Abdellahi L, Iraji F, Mahmoudabadi A, Hejazi SH (2022) Vaccination in leishmaniasis: a review Article. Iran Biomed J 26:1","journal-title":"Iran Biomed J"},{"key":"827_CR3","first-page":"3","volume":"44","author":"RZ Zhao","year":"2019","unstructured":"Zhao RZ, Jiang S, Zhang L, Yu ZB (2019) Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med 44:3\u201315","journal-title":"Int J Mol Med"},{"key":"827_CR4","doi-asserted-by":"crossref","unstructured":"Kaye PM, Matlashewski G, Mohan S, Le Rutte E, Mondal D, Khamesipour A, Malvolti S (2023) Vaccine value profile for leishmaniasis. vaccine.;41:S153-S75","DOI":"10.1016\/j.vaccine.2023.01.057"},{"key":"827_CR5","doi-asserted-by":"publisher","first-page":"639801","DOI":"10.3389\/fcimb.2021.639801","volume":"11","author":"T Pacheco-Fernandez","year":"2021","unstructured":"Pacheco-Fernandez T, Volpedo G, Gannavaram S, Bhattacharya P, Dey R, Satoskar A et al (2021) Revival of leishmanization and Leishmanin. Front Cell Infect Microbiol 11:639801","journal-title":"Front Cell Infect Microbiol"},{"key":"827_CR6","doi-asserted-by":"publisher","first-page":"105173","DOI":"10.1016\/j.actatropica.2019.105173","volume":"200","author":"M Mohebali","year":"2019","unstructured":"Mohebali M, Nadim A, Khamesipour A (2019) An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccines. Acta Trop 200:105173","journal-title":"Acta Trop"},{"key":"827_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/pathogens11040431","volume":"11","author":"G Volpedo","year":"2022","unstructured":"Volpedo G, Bhattacharya P, Gannavaram S, Pacheco-Fernandez T, Oljuskin T, Dey R et al (2022) The history of live attenuated centrin gene-deleted leishmania vaccine candidates. Pathogens 11:431","journal-title":"Pathogens"},{"key":"827_CR8","doi-asserted-by":"publisher","first-page":"107849","DOI":"10.1016\/j.exppara.2020.107849","volume":"210","author":"A Zabala-Pe\u00f1afiel","year":"2020","unstructured":"Zabala-Pe\u00f1afiel A, Todd D, Daneshvar H, Burchmore R (2020) The potential of live attenuated vaccines against cutaneous leishmaniasis. Exp Parasitol 210:107849","journal-title":"Exp Parasitol"},{"key":"827_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/microorganisms11041043","volume":"11","author":"PO Moreira","year":"2023","unstructured":"Moreira PO, Nogueira PM, Monte-Neto RL (2023) Next-Generation leishmanization: revisiting molecular targets for selecting genetically engineered Live-Attenuated leishmania. Microorganisms 11:1043","journal-title":"Microorganisms"},{"key":"827_CR10","doi-asserted-by":"publisher","first-page":"e12762","DOI":"10.1111\/pim.12762","volume":"42","author":"M Nateghi Rostami","year":"2020","unstructured":"Nateghi Rostami M (2020) CRISPR\/Cas9 gene drive technology to control transmission of vector-borne parasitic infections. Parasite Immunol 42:e12762","journal-title":"Parasite Immunol"},{"key":"827_CR11","doi-asserted-by":"publisher","first-page":"170095","DOI":"10.1098\/rsos.170095","volume":"4","author":"T Beneke","year":"2017","unstructured":"Beneke T, Madden R, Makin L, Valli J, Sunter J, Gluenz E (2017) A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids. Royal Soc Open Sci 4:170095","journal-title":"Royal Soc Open Sci"},{"key":"827_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molbiopara.2010.09.002","volume":"175","author":"GS Burkard","year":"2011","unstructured":"Burkard GS, Jutzi P, Roditi I (2011) Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters. Mol Biochem Parasitol 175:91\u201394","journal-title":"Mol Biochem Parasitol"},{"key":"827_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3855\/jidc.8199","volume":"11","author":"M Nateghi Rostami","year":"2017","unstructured":"Nateghi Rostami M, Hossein Rashidi B, Nazari R, Aghsaghloo F, Habibi A (2017) A multiplex assay of Trichomonas vaginalis, chlamydia trachomatis and neisseria gonorrhoeae infections in genital specimens. J Infect Dev Ctries 11:833\u2013839","journal-title":"J Infect Dev Ctries"},{"key":"827_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00436-008-0921-8","volume":"103","author":"H Keshavarz Valian","year":"2008","unstructured":"Keshavarz Valian H, Khoshabe Abdollah Kenedy L, Nateghi Rostami M, Miramin Mohammadi A, Khamesipour A (2008) Role of Mycobacterium vaccae in the protection induced by first generation leishmania vaccine against murine model of leishmaniasis. Parasitol Res 103:21\u201328","journal-title":"Parasitol Res"},{"key":"827_CR15","doi-asserted-by":"publisher","first-page":"e12841","DOI":"10.1111\/pim.12841","volume":"43","author":"F Darzi","year":"2021","unstructured":"Darzi F, Davoudian R, Nateghi Rostami M (2021) Differential inflammatory responses associated with leishmania major and L tropica in culture. Parasite Immunol 43:e12841","journal-title":"Parasite Immunol"},{"key":"827_CR16","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1371\/journal.pntd.0000845","volume":"4","author":"M Nateghi Rostami","year":"2010","unstructured":"Nateghi Rostami M, Keshavarz H, Edalat R, Sarrafnejad A, Shahrestani T, Mahboudi F, Khamesipour A (2010) CD8\u2009+\u2009T cells as a source of IFN-\u03b3 production in human cutaneous leishmaniasis. PLoS Negl Trop Dis 4:e845","journal-title":"PLoS Negl Trop Dis"},{"key":"827_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","volume":"7","author":"RG Titus","year":"1985","unstructured":"Titus RG, Marchand M, Boon T, Louis J (1985) A limiting Dilution assay for quantifying leishmania major in tissues of infected mice. Parasite Immunol 7:545\u2013555","journal-title":"Parasite Immunol"},{"key":"827_CR18","doi-asserted-by":"crossref","unstructured":"TASWELL C (1987) Limiting Dilution assays for the separation, characterization, and quantitation of biologically active particles and their clonal progeny. Cell Separation, Elsevier, pp 109\u2013145","DOI":"10.1016\/B978-0-12-564504-1.50009-X"},{"key":"827_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4049\/jimmunol.139.1.221","volume":"139","author":"P Scott","year":"1987","unstructured":"Scott P, Pearce E, Natovitz P, Sher A (1987) Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J Immunol (Baltimore Md: 1950) 139:221\u2013227","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"827_CR20","first-page":"126","volume":"15","author":"A Miramin-Mohammadi","year":"2021","unstructured":"Miramin-Mohammadi A, Javadi A, Eskandari SE, Nateghi-Rostami M, Khamesipour A (2021) Immune responses in cutaneous leishmaniasis: in vitro Thelper1\/Thelper2 cytokine profiles using live versus killed leishmania major. J Arthropod Borne Dis 15:126\u2013135","journal-title":"J Arthropod Borne Dis"},{"key":"827_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-016-0072-z","volume":"6","author":"R Singh","year":"2016","unstructured":"Singh R, Purkait B, Abhishek K, Saini S, Das S, Verma S et al (2016) Universal minicircle sequence binding protein of leishmania donovani regulates pathogenicity by controlling expression of cytochrome-b. Cell Bioscience 6:1\u201317","journal-title":"Cell Bioscience"},{"key":"827_CR22","first-page":"189","volume-title":"LeishGEdit: a method for rapid gene knockout and tagging using CRISPR-Cas9","author":"T Beneke","year":"2019","unstructured":"Beneke T, Gluenz E (2019) LeishGEdit: a method for rapid gene knockout and tagging using CRISPR-Cas9. Methods and Protocols, Springer,, Leishmania, pp 189\u2013210"},{"key":"827_CR23","doi-asserted-by":"crossref","unstructured":"Martel D, Beneke T, Gluenz E, Sp\u00e4th GF, Rachidi N Characterisation of casein kinase 1.1 in leishmania donovani using the CRISPR Cas9 toolkit. BioMed research international 2017;2017.","DOI":"10.1155\/2017\/4635605"},{"key":"827_CR24","doi-asserted-by":"publisher","first-page":"e0284240","DOI":"10.1371\/journal.pone.0284240","volume":"18","author":"T Nemati Haravani","year":"2023","unstructured":"Nemati Haravani T, Parvizi P, Hejazi SH, Sedaghat MM, Eskandarian A, Nateghi Rostami M (2023) Evaluation of expression variations in virulence-related genes of leishmania major after several culture passages compared with phlebotomus Papatasi isolated promastigotes. PLoS ONE 18:e0284240","journal-title":"PLoS ONE"},{"key":"827_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/nar\/gkn927","volume":"37","author":"D Sela","year":"2009","unstructured":"Sela D, Shlomai J (2009) Regulation of UMSBP activities through redox-sensitive protein domains. Nucleic Acids Res 37:279\u2013288","journal-title":"Nucleic Acids Res"},{"key":"827_CR26","doi-asserted-by":"publisher","first-page":"25703","DOI":"10.1074\/jbc.M402794200","volume":"279","author":"A Selvapandiyan","year":"2004","unstructured":"Selvapandiyan A, Debrabant A, Duncan R, Muller J, Salotra P, Sreenivas G et al (2004) Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in leishmania. J Biol Chem 279:25703\u201325710","journal-title":"J Biol Chem"},{"key":"827_CR27","doi-asserted-by":"crossref","unstructured":"Moreira POL, Nogueira PM, Monte-Neto RL (2023) Next-Generation Next-Generation Leishmanization: Revisiting Molecular Targets for Selecting Genetically Engineered Live-Attenuated Leishmania","DOI":"10.3390\/microorganisms11041043"},{"key":"827_CR28","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","volume":"10","author":"C Bogdan","year":"2008","unstructured":"Bogdan C (2008) Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol 10:1221\u20131234","journal-title":"Cell Microbiol"},{"key":"827_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-016-1777-x","volume":"9","author":"SC Mendon\u00e7a","year":"2016","unstructured":"Mendon\u00e7a SC (2016) Differences in immune responses against leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery. Parasites Vectors 9:1\u20139","journal-title":"Parasites Vectors"},{"key":"827_CR30","doi-asserted-by":"publisher","first-page":"1304696","DOI":"10.3389\/fimmu.2024.1304696","volume":"15","author":"M Nateghi-Rostami","year":"2024","unstructured":"Nateghi-Rostami M, Sohrabi Y, Memory T (2024) Cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis. Front Immunol 15:1304696","journal-title":"Front Immunol"},{"key":"827_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1385\/IR:27:2-3:489","volume":"27","author":"P Scott","year":"2003","unstructured":"Scott P (2003) Development and regulation of cell-mediated immunity in experimental leishmaniasis. Immunol Res 27:489\u2013498","journal-title":"Immunol Res"},{"key":"827_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nri933","volume":"2","author":"D Sacks","year":"2002","unstructured":"Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to leishmania major in mice. Nat Rev Immunol 2:845\u2013858","journal-title":"Nat Rev Immunol"},{"key":"827_CR33","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1002\/eji.200323163","volume":"33","author":"LE Rosas","year":"2003","unstructured":"Rosas LE, Keiser T, Pyles R, Durbin J, Satoskar AR (2003) Development of protective immunity against cutaneous leishmaniasis is dependent on STAT1-mediated IFN signaling pathway. Eur J Immunol 33:1799\u20131805","journal-title":"Eur J Immunol"},{"key":"827_CR34","doi-asserted-by":"publisher","first-page":"969","DOI":"10.4049\/jimmunol.165.2.969","volume":"165","author":"Y Belkaid","year":"2000","unstructured":"Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D (2000) A natural model of leishmania major infection reveals a prolonged silent phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 165:969\u2013977","journal-title":"J Immunol"},{"key":"827_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0952-7915(99)00052-7","volume":"12","author":"C Bogdan","year":"2000","unstructured":"Bogdan C, R\u00f6llinghoff M, Diefenbach A (2000) Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12:64\u201376","journal-title":"Curr Opin Immunol"},{"key":"827_CR36","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1590\/S0100-879X2005000700001","volume":"38","author":"A Campos-Neto","year":"2005","unstructured":"Campos-Neto A (2005) What about Th1\/Th2 in cutaneous leishmaniasis vaccine discovery? Braz J Med Biol Res 38:979\u2013984","journal-title":"Braz J Med Biol Res"},{"key":"827_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00430-021-00703-8","volume":"210","author":"M Nateghi Rostami","year":"2021","unstructured":"Nateghi Rostami M, Khamesipour A (2021) Potential biomarkers of immune protection in human leishmaniasis. Med Microbiol Immunol 210:81\u2013100","journal-title":"Med Microbiol Immunol"},{"key":"827_CR38","first-page":"89","volume":"27","author":"M Nateghi Rostami","year":"2010","unstructured":"Nateghi Rostami M, Keshavarz H, Khamesipour A (2010) Immune response of BALB\/c mice against an experimental vaccine of alum precipitated autoclaved leishmania major (Alum-ALM) mixed with BCG or Mycobacterium vaccae. Trop Biomed 27:89\u2013102","journal-title":"Trop Biomed"},{"key":"827_CR39","doi-asserted-by":"publisher","first-page":"864031","DOI":"10.3389\/fimmu.2022.864031","volume":"13","author":"N Ismail","year":"2022","unstructured":"Ismail N, Karmakar S, Bhattacharya P, Sepahpour T, Takeda K, Hamano S et al (2022) Leishmania major centrin Gene-Deleted parasites generate skin resident memory T-Cell immune response analogous to leishmanization. Front Immunol 13:864031","journal-title":"Front Immunol"},{"key":"827_CR40","doi-asserted-by":"publisher","first-page":"e1004538","DOI":"10.1371\/journal.ppat.1004538","volume":"10","author":"NC Peters","year":"2014","unstructured":"Peters NC, Pag\u00e1n AJ, Lawyer PG, Hand TW, Henrique Roma E, Stamper LW et al (2014) Chronic parasitic infection maintains high frequencies of short-lived Ly6C\u2009+\u2009CD4\u2009+\u2009effector T cells that are required for protection against re-infection. PLoS Pathog 10:e1004538","journal-title":"PLoS Pathog"},{"key":"827_CR41","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1038\/s41467-020-17154-z","volume":"11","author":"W-W Zhang","year":"2020","unstructured":"Zhang W-W, Karmakar S, Gannavaram S, Dey R, Lypaczewski P, Ismail N et al (2020) A second generation leishmanization vaccine with a markerless attenuated leishmania major strain using CRISPR gene editing. Nat Commun 11:3461","journal-title":"Nat Commun"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-025-00827-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:56:38Z","timestamp":1767095798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-025-00827-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1007\/s00430-025-00827-1","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of Pasteur Institute of Iran (No. IR.PII.REC.1399.030) on September 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}